Andrew J. Leger

2.0k total citations
16 papers, 1.6k citations indexed

About

Andrew J. Leger is a scholar working on Molecular Biology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Andrew J. Leger has authored 16 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Andrew J. Leger's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Glycogen Storage Diseases and Myoclonus (2 papers) and Platelet Disorders and Treatments (2 papers). Andrew J. Leger is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Glycogen Storage Diseases and Myoclonus (2 papers) and Platelet Disorders and Treatments (2 papers). Andrew J. Leger collaborates with scholars based in United States, France and United Kingdom. Andrew J. Leger's co-authors include Athan Kuliopulos, Lidija Covic, Nicole C. Kaneider, Seng H. Cheng, Bruce M. Wentworth, Anika Agarwal, Claudia K. Derian, Thurman M. Wheeler, C. Frank Bennett and Charles A. Thornton and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Andrew J. Leger

16 papers receiving 1.6k citations

Peers

Andrew J. Leger
Katie O’Callaghan United States
Y Yazaki Japan
Raudel Sandoval United States
John Doukas United States
Geoffrey I. Johnston United Kingdom
Andrew J. Leger
Citations per year, relative to Andrew J. Leger Andrew J. Leger (= 1×) peers Morley D. Hollenberg

Countries citing papers authored by Andrew J. Leger

Since Specialization
Citations

This map shows the geographic impact of Andrew J. Leger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J. Leger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J. Leger more than expected).

Fields of papers citing papers by Andrew J. Leger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J. Leger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J. Leger. The network helps show where Andrew J. Leger may publish in the future.

Co-authorship network of co-authors of Andrew J. Leger

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J. Leger. A scholar is included among the top collaborators of Andrew J. Leger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J. Leger. Andrew J. Leger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Pollack, Daniel & Andrew J. Leger. (2019). Broken Trust: Getting Justice for a Sexually Groomed and Sexually Abused Young Athlete.. 1 indexed citations
2.
Zhang, Ping, Andrew J. Leger, James Baleja, et al.. (2015). Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics. Journal of Biological Chemistry. 290(25). 15785–15798. 28 indexed citations
3.
Clayton, Nicholas P., Carol A. Nelson, Timothy Weeden, et al.. (2015). Antisense oligonucleotide-mediated suppression of muscle glycogen synthase 1 synthesis as an approach for substrate reduction therapy of Pompe disease. Molecular Genetics and Metabolism. 114(2). S32–S32. 19 indexed citations
4.
Clayton, Nicholas P., Carol A. Nelson, Timothy Weeden, et al.. (2014). Antisense Oligonucleotide-mediated Suppression of Muscle Glycogen Synthase 1 Synthesis as an Approach for Substrate Reduction Therapy of Pompe Disease. Molecular Therapy — Nucleic Acids. 3. e206–e206. 55 indexed citations
5.
Leger, Andrew J., Nicholas P. Clayton, I‐Huan Wu, et al.. (2013). Systemic Delivery of a Peptide-Linked Morpholino Oligonucleotide Neutralizes Mutant RNA Toxicity in a Mouse Model of Myotonic Dystrophy. Nucleic Acid Therapeutics. 23(2). 109–117. 49 indexed citations
6.
Wheeler, Thurman M., Andrew J. Leger, Sanjay K. Pandey, et al.. (2012). Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature. 488(7409). 111–115. 383 indexed citations
7.
Leger, Andrew J., Lingyun Li, Wei‐Lien Chuang, et al.. (2011). Adeno‐associated virus‐mediated expression of acid sphingomyelinase decreases atherosclerotic lesion formation in apolipoprotein E−/− mice. The Journal of Gene Medicine. 13(6). 324–332. 17 indexed citations
8.
Leger, Andrew J., Adam J. Belanger, Antonius Song, et al.. (2010). Inhibition of osteoclastogenesis by prolyl hydroxylase inhibitor dimethyloxallyl glycine. Journal of Bone and Mineral Metabolism. 28(5). 510–519. 32 indexed citations
9.
Trivedi, Vishal, Adrienne Boire, Boris Tchernychev, et al.. (2009). Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site. Cell. 137(2). 332–343. 190 indexed citations
10.
Kaneider, Nicole C., Andrew J. Leger, Anika Agarwal, et al.. (2007). 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nature Immunology. 8(12). 1303–1312. 191 indexed citations
11.
Kaneider, Nicole C., Andrew J. Leger, & Athan Kuliopulos. (2006). Therapeutic targeting of molecules involved in leukocyte–endothelial cell interactions. FEBS Journal. 273(19). 4416–4424. 67 indexed citations
12.
Leger, Andrew J., Lidija Covic, & Athan Kuliopulos. (2006). Protease-Activated Receptors in Cardiovascular Diseases. Circulation. 114(10). 1070–1077. 233 indexed citations
13.
Leger, Andrew J., Suzanne L. Jacques, Nicole C. Kaneider, et al.. (2006). Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis. Circulation. 113(9). 1244–1254. 178 indexed citations
14.
Kaneider, Nicole C., Anika Agarwal, Andrew J. Leger, & Athan Kuliopulos. (2005). Reversing systemic inflammatory response syndrome with chemokine receptor pepducins. Nature Medicine. 11(6). 661–665. 112 indexed citations
15.
Swift, Steven M., et al.. (2005). Role of the PAR1 Receptor 8th Helix in Signaling. Journal of Biological Chemistry. 281(7). 4109–4116. 71 indexed citations
16.
Love, Tara M., et al.. (2005). Activation of CREB/ATF Sites by Polyomavirus Large T Antigen. Journal of Virology. 79(7). 4180–4190. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026